Toxic hepatitis with isoniazid and rifampin. A meta-analysis.

Suppr

超能文献

作者信息

Steele M A, Burk R F, DesPrez R M

机构信息

Nashville Veterans Affairs Medical Center 37212-2637.

出版信息

Chest. 1991 Feb;99(2):465-71. doi: 10.1378/chest.99.2.465.

DOI:10.1378/chest.99.2.465

PMID:1824929

Abstract

摘要

相似文献

Toxic hepatitis with isoniazid and rifampin. A meta-analysis.

Chest. 1991 Feb;99(2):465-71. doi: 10.1378/chest.99.2.465.

[Fulminating hepatitis caused by administration of isoniazid and rifampicin in a patient under chronic treatment with barbiturates].[一名长期接受巴比妥类药物治疗的患者在服用异烟肼和利福平后引发暴发性肝炎]

Ned Tijdschr Geneeskd. 1980 Jun 21;124(25):1008-12.

[Drug-induced hepatitis during a treatment associating isoniazid and rifampicin].[异烟肼和利福平联合治疗期间的药物性肝炎]

Ann Pediatr (Paris). 1972 Apr;19(4):307-11.

[Toxic hepatitis caused by rifampin and isoniazid in treatment of tuberculosis (author's transl)].利福平与异烟肼治疗结核病所致中毒性肝炎（作者译）

An Esp Pediatr. 1977 Feb;10(2):167-70.

[Fulminant hepatitis in patients with mixed connective tissue disease under antitubercular treatment with hydrazide and rifampicin].[在接受肼屈嗪和利福平抗结核治疗的混合性结缔组织病患者中发生的暴发性肝炎]

Rev Hosp Clin Fac Med Sao Paulo. 1982 Feb;37(1):48-51.

[Detection of the effects of the rifampin-isoniazid combination on the human liver].[利福平-异烟肼组合对人体肝脏影响的检测]

Nouv Presse Med. 1974 Mar 23;3(12):727-32.

Increased incidence of hepatitis induced by isoniazid-rifampin combination in children.儿童中异烟肼-利福平联合用药所致肝炎发病率增加。

J Pediatr. 1982 Jan;100(1):174. doi: 10.1016/s0022-3476(82)80277-1.

[Hepatitis during rifampicin and isoniazid treatment of a patient with generalized tuberculosis].[利福平与异烟肼治疗全身型结核病患者期间出现的肝炎]

Probl Tuberk. 1989(9):72-3.

Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.异烟肼-利福平治疗结核病所致肝炎的诱发因素。

Am Rev Respir Dis. 1978 Sep;118(3):461-6. doi: 10.1164/arrd.1978.118.3.461.

Hepatotoxicity from isoniazid and rifampin among children treated for tuberculosis.接受抗结核治疗的儿童中异烟肼和利福平所致的肝毒性。

Pediatrics. 1983 Oct;72(4):491-9.

引用本文的文献

Artificial intelligence for tuberculosis control: a scoping review of applications in public health.用于结核病防控的人工智能：公共卫生应用的范围综述

J Glob Health. 2025 Jul 25;15:04192. doi: 10.7189/jogh.15.04192.

Understanding antituberculosis drug-induced hepatotoxicity: Risk factors and effective management strategies in the pediatric population.了解抗结核药物引起的肝毒性：儿科人群中的危险因素及有效管理策略

World J Clin Pediatr. 2025 Jun 9;14(2):101875. doi: 10.5409/wjcp.v14.i2.101875.

Use of putative hepatoprotective agents as an adjunct to anti-TB treatment in Europe.在欧洲，使用假定的肝保护剂作为抗结核治疗的辅助手段。

IJTLD Open. 2025 Feb 1;2(2):101-106. doi: 10.5588/ijtldopen.24.0498. eCollection 2025 Feb.

Clinical perspectives of isoniazid-induced liver injury.异烟肼所致肝损伤的临床观点

Liver Res. 2021 Feb 11;5(2):45-52. doi: 10.1016/j.livres.2021.02.001. eCollection 2021 Jun.

*05:01 and *11:01 Is Associated with Adverse Drug Reactions to Isoniazid and Rifampin for Treatment of Latent Tuberculosis Infection in South Korea.05:01和11:01与韩国潜伏性结核感染治疗中异烟肼和利福平的药物不良反应相关。

J Clin Med. 2024 Jun 18;13(12):3563. doi: 10.3390/jcm13123563.

Discovery of potent antimycobacterial agents targeting lumazine synthase (RibH) of Mycobacterium tuberculosis.发现针对结核分枝杆菌亮氨酸合酶（RibH）的强效抗分枝杆菌药物。

Sci Rep. 2024 May 28;14(1):12170. doi: 10.1038/s41598-024-63051-6.

Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis.一项3期试验的药代动力学-药效学证据支持利福平治疗结核病的固定剂量给药方案。

Clin Infect Dis. 2024 Jun 14;78(6):1680-1689. doi: 10.1093/cid/ciae119.

Safety and outcome of treatment of latent tuberculosis infection in liver transplant recipients.肝移植受者潜伏性结核感染治疗的安全性和结局。

Infection. 2024 Jun;52(3):1055-1061. doi: 10.1007/s15010-023-02161-1. Epub 2024 Feb 13.

Potential drug-drug interactions of frequently prescribed medications in long COVID detected by two electronic databases.通过两个电子数据库检测到长新冠患者常用药物的潜在药物-药物相互作用。

PLoS One. 2023 Nov 16;18(11):e0293866. doi: 10.1371/journal.pone.0293866. eCollection 2023.

infection successfully treated with clarithromycin, rifampicin, and ethambutol.感染已用克拉霉素、利福平及乙胺丁醇成功治愈。

Respir Med Case Rep. 2023 Jul 8;45:101894. doi: 10.1016/j.rmcr.2023.101894. eCollection 2023.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验